Ingredion AI Stock Analysis
Ingredion (CNP) AI Stock Analysis
Ingredion
(BX Swiss:CNP)
No summary available
Ingredion Business Overview & Revenue Model
Company Description
Ingredion Incorporated, along with its affiliated entities, specializes in the global production and sale of starches and sweeteners, catering to a diverse range of industries. The company's operations are strategically organized into four geographic...
Ingredion Earnings Call Summary
The call had some meaningful operational and strategic positives, including continued Texture & Healthful Solutions volume growth, strong Clean Label momentum, LATAM volume growth, Argo production stabilization, progress on the Tate & Lyle transaction, and ongoing shareholder returns. However, these positives were outweighed by a 19% decline in adjusted operating income, lower adjusted EPS, persistent Argo cost and yield issues, record tapioca costs, weaker U.S./Canada demand, currency and earthquake impacts, declining cash flow, and a reduced full-year outlook.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For the full year 2026, Ingredion anticipates net sales to be flat, adjusted operating income to be down mid-teens, and adjusted EPS to be in the range of $9.25-$9.70, assuming diluted shares outstanding of 63.5 million to 64 million, including completion of the planned $100 million of share repurchases; cash from operations is expected to be in the range of $650 million-$750 million and capital expenditures between $450 million-$490 million. By segment, Texture & Healthful Solutions net sales are expected to be up low single digits and operating income flat to up low single digits; Food & Industrial Ingredients LATAM net sales up low to mid-single digits and operating income down mid to high single digits; Food & Industrial Ingredients U.S./Canada net sales down mid-single digits and operating income down 35%-40%; and All other net sales down 20%-25%, with an operating loss approximately $15 million. Guidance reflects current tariff levels in effect at the end of October 2026 and excludes any acquisition-related integration and restructuring costs, as well as any potential impairment costs; the Tate & Lyle transaction remains targeted to close in the second half of 2027.
Ingredion Risk Analysis
Ingredion disclosed 35 risk factors in its most recent earnings report. Ingredion reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksIngredion Peers Comparison
Overall Rating
MKC77Outperform
DAR76Outperform
MZTI74Outperform
JJSF68Neutral
JBSS63Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | $12.64B | 8.46 | 22.32% | 4.09% | 13.23% | 91.32% | |
| 76Outperform | $8.67B | 10.46 | 16.72% | ― | 15.79% | 687.52% | |
| 74Outperform | $3.02B | 17.48 | 16.83% | 3.60% | -0.94% | 2.86% | |
| 68Neutral | $1.65B | 33.81 | 5.40% | 3.62% | -4.69% | -39.51% | |
| 63Neutral | $690.62M | 12.28 | 14.95% | 7.62% | 3.13% | -14.89% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DAR | Darling Ingredients | 55.99 | 21.56 | 62.62% | |
| JJSF | J & J Snack Foods | 88.39 | 7.51 | 9.28% | |
| JBSS | John B. Sanfilippo & Son | 59.06 | -5.32 | -8.26% | |
| MZTI | Marzetti Company | 110.97 | -51.94 | -31.88% | |
| MKC | McCormick & Company Inc | 46.96 | -15.36 | -24.65% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
